WO2023126026A3 - Epa-ee纳米脂质组合物、及其制剂、制备方法和应用 - Google Patents

Epa-ee纳米脂质组合物、及其制剂、制备方法和应用 Download PDF

Info

Publication number
WO2023126026A3
WO2023126026A3 PCT/CN2023/078639 CN2023078639W WO2023126026A3 WO 2023126026 A3 WO2023126026 A3 WO 2023126026A3 CN 2023078639 W CN2023078639 W CN 2023078639W WO 2023126026 A3 WO2023126026 A3 WO 2023126026A3
Authority
WO
WIPO (PCT)
Prior art keywords
epa
nanocomposite
lipid
formulation
preparation
Prior art date
Application number
PCT/CN2023/078639
Other languages
English (en)
French (fr)
Other versions
WO2023126026A2 (zh
Inventor
甘勇
张馨欣
郭琳苗
缪云秋
王晓丽
章莹
朱春柳
Original Assignee
中国科学院上海药物研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中国科学院上海药物研究所 filed Critical 中国科学院上海药物研究所
Publication of WO2023126026A2 publication Critical patent/WO2023126026A2/zh
Publication of WO2023126026A3 publication Critical patent/WO2023126026A3/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EPA-EE纳米脂质组合物、及其制剂、制备方法和应用。该EPA-EE纳米脂质组合物以具有高含量EPA-EE的原料为主要成分,且乳化剂中含有高不饱和磷脂，可制成纳米级别的亚微乳，用作口服制剂。
PCT/CN2023/078639 2021-12-29 2023-02-28 Epa-ee纳米脂质组合物、及其制剂、制备方法和应用 WO2023126026A2 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111640995.4A CN116407543A (zh) 2021-12-29 2021-12-29 Epa-ee纳米脂质组合物、及其制剂、制备方法和应用
CN202111640995.4 2021-12-29

Publications (2)

Publication Number Publication Date
WO2023126026A2 WO2023126026A2 (zh) 2023-07-06
WO2023126026A3 true WO2023126026A3 (zh) 2023-08-24

Family

ID=86998238

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/078639 WO2023126026A2 (zh) 2021-12-29 2023-02-28 Epa-ee纳米脂质组合物、及其制剂、制备方法和应用

Country Status (2)

Country Link
CN (1) CN116407543A (zh)
WO (1) WO2023126026A2 (zh)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120065264A1 (en) * 2009-05-22 2012-03-15 Hirosato Fujii SELF-EMULSIFYING COMPOSITION OF w3 FATTY ACID
CN102421422A (zh) * 2009-03-09 2012-04-18 普罗诺瓦生物医药挪威公司 含有脂肪酸油混合物和表面活性剂的组合物及其方法和用途
WO2014095628A1 (en) * 2012-12-17 2014-06-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa)
CN104739763A (zh) * 2013-12-31 2015-07-01 中国科学院上海药物研究所 一种具有抗炎和抗血栓形成作用的静脉注射用脂肪乳剂及其制备方法和用途
CN105530927A (zh) * 2013-07-18 2016-04-27 持田制药株式会社 ω-3脂肪酸的自乳化组合物
CN105939706A (zh) * 2014-01-28 2016-09-14 费森尤斯卡比德国有限公司 用于肠胃外给药的包含epa乙酯和dha乙酯的组合物
CN110636863A (zh) * 2017-05-18 2019-12-31 丘比株式会社 具有自乳化性的组合物及其制造方法及纳米乳液及其制造方法
CN113116811A (zh) * 2020-01-14 2021-07-16 中国科学院上海药物研究所 可注射长效镇痛药物组合物及其制备方法和用途
WO2021156385A1 (en) * 2020-02-04 2021-08-12 Wellness Holding B.V. Lipid composition comprising omega-3 fatty acids

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102421422A (zh) * 2009-03-09 2012-04-18 普罗诺瓦生物医药挪威公司 含有脂肪酸油混合物和表面活性剂的组合物及其方法和用途
US20120065264A1 (en) * 2009-05-22 2012-03-15 Hirosato Fujii SELF-EMULSIFYING COMPOSITION OF w3 FATTY ACID
WO2014095628A1 (en) * 2012-12-17 2014-06-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa)
CN105530927A (zh) * 2013-07-18 2016-04-27 持田制药株式会社 ω-3脂肪酸的自乳化组合物
CN104739763A (zh) * 2013-12-31 2015-07-01 中国科学院上海药物研究所 一种具有抗炎和抗血栓形成作用的静脉注射用脂肪乳剂及其制备方法和用途
CN105939706A (zh) * 2014-01-28 2016-09-14 费森尤斯卡比德国有限公司 用于肠胃外给药的包含epa乙酯和dha乙酯的组合物
CN110636863A (zh) * 2017-05-18 2019-12-31 丘比株式会社 具有自乳化性的组合物及其制造方法及纳米乳液及其制造方法
CN113116811A (zh) * 2020-01-14 2021-07-16 中国科学院上海药物研究所 可注射长效镇痛药物组合物及其制备方法和用途
WO2021156385A1 (en) * 2020-02-04 2021-08-12 Wellness Holding B.V. Lipid composition comprising omega-3 fatty acids

Also Published As

Publication number Publication date
CN116407543A (zh) 2023-07-11
WO2023126026A2 (zh) 2023-07-06

Similar Documents

Publication Publication Date Title
CY1120165T1 (el) Μεθοδοι για την παραγωγη εναιωρηματος αριπιπραζολης και κρυο-αποξηραμενης φαρμακοτεχνικης μορφης
JP2011255373A5 (zh)
EP2065043A4 (en) PROSTAGLANDINE FATTY EMULSION, PROCESS FOR PRODUCING THE SAME, METHOD FOR STABILIZING THE SAME, AND EMULSIFYING AGENT
MX2021011297A (es) Composiciones para el cuidado bucal para el suministro de agente activo.
TW200503643A (en) Active compound-comprising adsorbates
BR112017025163A2 (pt) dispersões de materiais de grafeno perfurado e aplicações dos mesmos
TWD207874S (zh) 電連接器
TWD205359S (zh) 電連接器
TWD205358S (zh) 電連接器
PA8784701A1 (es) Proceso y dispersión sólida que contiene revaprazan para la preparación del mismo
MY186442A (en) High internal phase water-in-oil type cosmetic composition
AU2001249959A1 (en) Method of making an aqueous dispersion of fluoropolymers
MX2022009964A (es) Vacuna contra hpv.
WO2023126026A3 (zh) Epa-ee纳米脂质组合物、及其制剂、制备方法和应用
BR112021021219A2 (pt) Micro-organismo com capacidade de produção de l-histidina melhorada e método para produzir histidina com uso do mesmo
PH12019500446A1 (en) Epoxy emulsion and preparation method therefor
WO2020146700A8 (en) Lipid nanoparticles
BR112019015971A2 (pt) Sistema e método para sincronização de interações de reunião notarial entre múltiplos clientes de software
ATE391163T1 (de) O/w-emulgator, o/w-emulsion und deren verwendungen
BR112018010549A2 (pt) método para tratamento de sementes
MY173159A (en) Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer
MX2018010755A (es) Pelicula transmucosal de montelukast.
DK0629128T3 (da) Vandig phospholipidvesikeldispersion, fremgangsmåde til fremstilling deraf samt anvendelse deraf
BR112022016798A2 (pt) Emulsão de óleo em água que compreende um material de lipídio sólido
BR112016021692A2 (pt) Métodos de preparação de uma composição imunogênica e de aperfeiçoamento de potência imunoestimuladora de vacinas adsorvidas em sal de alumínio, composição imunogênica e uso de uma composição de l(mpla)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23735131

Country of ref document: EP

Kind code of ref document: A2